Effects of ePRO Monitoring on the Quality of Life of Patients With HNC
Cancer
CANCER
Patient-reported quality-of-life items from the EORTC QLQ-C30 questionnaire and H&N35 at the time of radiotherapy completion were analyzed and compared between the trial arms. Global health was comparable between patients undergoing ePRO monitoring and those receiving standard-of-care monitoring (median 66.67 and Comparison of functional and symptom scales upon completion of radiotherapy between patients undergoing electronic patient-reported outcome (ePRO) monitoring and those receiving standard-of-care monitoring. Items were assessed by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (QLQ-C30) questionnaire. High values in the functioning scales represent a high level of functioning, whereas high levels in symptom scales represent a high level of symptom burden. Graphs depict median values (bold black lines) and IQRs.In contrast, the HNC-specific symptom burden, as assessed by H&N35, appeared significantly higher in several domains for patients monitored daily using ePROs (Comparison of symptom burden upon completion of radiotherapy between patients undergoing ePRO monitoring and those receiving standard-of-care monitoring. Items were assessed by the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Head and Neck Module (QLQ-H&N35) module. High values in the functioning scales represent a high level of functioning, whereas high levels in symptom scales represent a high level of symptom burden. Graphs depict median values (bold black lines) and IQRs.